There’s a new twist in the Pfizer activist shareholder campaign. We see a clear sign that the biotech job market is rough, because fewer new doctorates are escaping academia for industry.

Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pfizer has earned a nod from the U.S. regulator for another of its products in the indication. On Friday, the FDA signed ...

Pfizer's COVID-19 products continue to generate significant cash flow that helps bolster the company's dividend. The big drugmaker has opportunities to monetize assets to raise additional cash ...

Are you a print subscriber? Activate your account. By Tim Nudd - 1 hour 14 min ago By Adrianne Pasquarelli - 5 hours 42 min ago By Erika Wheless - 5 hours 42 min ago By Brian Bonilla - 5 hours 42 ...

Pfizer stock (NYSE: PFE) currently trades at $29 per share, 45% below its peak level of $54 seen in December 2021. In contrast, Merck stock is up 54% over this period. PFE stock was trading at $47 ...

When former executives team up with an activist investor to “help” a struggling company, it is often bad news for the current chief executive.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Pfizer PFE-0.77%decrease; red down pointing triangle punched back against activist investor Starboard Value on Tuesday, delivering positive quarterly results. The pharmaceutical company raised its ...

(Reuters) -Pfizer CEO Albert Bourla, under pressure from activist hedge fund Starboard Value, made his case to Wall Street on Tuesday that the drugmaker's turnaround is succeeding after it ...

The shots are also suggested for certain adults and children who are immunocompromised. A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by ...

US Health Advisers Back Pfizer, Merck Pneumonia Shots For Adults Over 50 Both Pfizer and Merck had asked the CDC to lower age recommendations to include adults 50 and up. Madison Muller, Bloomberg ...